Simvastatin plus Rifaximin to prevent ACLF in patients with decompensated cirrhosis. A randomised, double-blind, placebo-controlled, phase-3 trial: the liverhope efficacy trial

Elisa Pose, César Jiménez, Giacomo Zaccherini, Daniela Campion, Salvatore Piano, Frank Erhard Uschner, Koos de Wit, Olivier Roux, Kohilan Gananandan, Wim Laleman, Cristina Solé, Sonia Alonso Sáenz De Oger, Berta Cuyàs, Xavier Ariza, Adrià Juanola, Ann T., Laura Napoleone, Jordi Gratacós, Marta Tonon, Enrico Pompili, Jordi Sánchez‐Delgado, Marta Carol, Martina Pérez, Núria Fabrellas, Judit Pich, Claudia Martell, Georgina Casanovas, Gemma Domènech, Ferràn Torres, Víctor Manuel, Vargas Blasco, Paolo Caraceni, Carlo Alessandria, Paolo Angeli, Jonel Trebicka, Ulrich Beuers, Claire Francoz, Rajeshwar P. Mookerjee, Rafael Bañares, Germán Soriano, Rubén Hernáez, Andrew S. Allegretti, Manuel Morales‐Ruiz, Miquel Serra‐Burriel, Hugh Watson, Juan G. Abraldeṣ, Patrick S. Kamath, Pere Ginès